Intrinsic Up-Regulation of 2-AG Favors an Area Specific Neuronal Survival in Different In Vitro Models of Neuronal Damage

PLoS ONE

Volumn 7, Issue 12, 2012, Pages

  Kallendrusch, Sonja ^a,b   Hobusch, Constance ^a   Ehrlich, Angela ^a   Nowicki, Marcin ^a   Ziebell, Simone ^c   Bechmann, Ingo ^a   Geisslinger, Gerd ^c   Koch, Marco ^a   Dehghani, Faramarz ^a,d  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b LOEWE Lipid Signaling Forschungszentrum Frankfurt   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ACYLGLYCEROL LIPASE; DIACYLGLYCEROL LIPASE ALPHA; LIPOPROTEIN LIPASE; MESSENGER RNA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN SLICE; CELL LEVEL; CELL SUBPOPULATION; CELL SURVIVAL; DAGL GENE; DENDRITE; DENTATE GYRUS; DISEASE MODEL; DOWN REGULATION; ENTORHINAL CORTEX; ENZYME ACTIVITY; ENZYME LOCALIZATION; EXCITOTOXICITY; GENE; GENE EXPRESSION; HIPPOCAMPAL CA1 REGION; IMMUNOREACTIVITY; IN VITRO STUDY; MICROGLIA; NERVE CELL; NERVE CELL CULTURE; NERVE CELL LESION; NERVE TRANSECTION; NEUROPROTECTION; NONHUMAN; ORGANOTYPIC ENTORHINO HIPPOCAMPAL SLICE CULTURE; PERFORANT NERVE TRACT; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION; UPREGULATION;

ANIMALS; ARACHIDONIC ACIDS; ASTROCYTES; BENZODIOXOLES; CELL SURVIVAL; ENDOCANNABINOIDS; FEMALE; GENE KNOCKDOWN TECHNIQUES; GLYCERIDES; HIPPOCAMPUS; LIPOPROTEIN LIPASE; MICROGLIA; MONOACYLGLYCEROL LIPASES; N-METHYLASPARTATE; NEURONS; PERFORANT PATHWAY; PIPERIDINES; PROTEIN TRANSPORT; RATS, WISTAR; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 84871449655     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0051208     Document Type: Article

References (65)

1. Piomelli D, (2003) The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 4: 873-884.
2. Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, et al. (1999) Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 19: 2987-2995.
3. van der Stelt M, Veldhuis WB, Bar PR, Veldink GA, Vliegenthart JF, et al. (2001) Neuroprotection by Delta9-tetrahydrocannabinol, the main active compound in marijuana, against ouabain-induced in vivo excitotoxicity. J Neurosci 21: 6475-6479.
4. Panikashvili D, Simeonidou C, Ben-Shabat S, Hanus L, Breuer A, et al. (2001) An endogenous cannabinoid (2-AG) is neuroprotective after brain injury. Nature 413: 527-531.
5. Kreutz S, Koch M, Ghadban C, Korf HW, Dehghani F, (2007) Cannabinoids and neuronal damage: differential effects of THC, AEA and 2-AG on activated microglial cells and degenerating neurons in excitotoxically lesioned rat organotypic hippocampal slice cultures. Exp Neurol 203: 246-257.
6. Pisani V, Madeo G, Tassone A, Sciamanna G, Maccarrone M, et al. (2011) Homeostatic changes of the endocannabinoid system in Parkinson's disease. Mov Disord 26: 216-222.
7. Casteels C, Vandeputte C, Rangarajan JR, Dresselaers T, Riess O, et al. (2011) Metabolic and type 1 cannabinoid receptor imaging of a transgenic rat model in the early phase of Huntington disease. Exp Neurol 229: 440-449.
8. Zajicek JP, Apostu VI, (2011) Role of cannabinoids in multiple sclerosis. CNS Drugs 25: 187-201.
9. Mulder J, Zilberter M, Pasquare SJ, Alpar A, Schulte G, et al. (2011) Molecular reorganization of endocannabinoid signalling in Alzheimer's disease. Brain 134: 1041-1060.
10. Katona I, Freund TF, (2008) Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14: 923-930.
11. Koch M, Kreutz S, Bottger C, Benz A, Maronde E, et al. (2011) Palmitoylethanolamide protects dentate gyrus granule cells via peroxisome proliferator-activated receptor-alpha. Neurotox Res 19: 330-340.
12. Panikashvili D, Mechoulam R, Beni SM, Alexandrovich A, Shohami E, (2005) CB1 cannabinoid receptors are involved in neuroprotection via NF-kappa B inhibition. J Cereb Blood Flow Metab 25: 477-484.
13. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, et al. (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. Journal of Neuroscience 26: 5628-5637.
14. Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, et al. (2002) International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 54: 161-202.
15. Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, et al. (1995) 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 215: 89-97.
16. Freund TF, Katona I, Piomelli D, (2003) Role of endogenous cannabinoids in synaptic signaling. Physiol Rev 83: 1017-1066.
17. Dittel BN, (2008) Direct suppression of autoreactive lymphocytes in the central nervous system via the CB2 receptor. Br J Pharmacol 153: 271-276.
18. Maresz K, Pryce G, Ponomarev ED, Marsicano G, Croxford JL, et al. (2007) Direct suppression of CNS autoimmune inflammation via the cannabinoid receptor CB1 on neurons and CB2 on autoreactive T cells. Nat Med 13: 492-497.
19. Pertwee RG, Howlett AC, Abood ME, Alexander SP, Di Marzo V, et al. (2010) International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB and CB. Pharmacol Rev 62: 588-631.
20. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, et al. (2003) Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163: 463-468.
21. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, et al. (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99: 10819-10824.
22. Blankman JL, Simon GM, Cravatt BF, (2007) A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol. Chem Biol 14: 1347-1356.
23. Deller T, (1997) The anatomy of the rat fascia dentata-new vistas. Ann Anat 179: 501-504.
24. Frotscher M, Heimrich B, Deller T, (1997) Sprouting in the hippocampus is layer-specific. Trends Neurosci 20: 218-223.
25. Kovac AD, Kwidzinski E, Heimrich B, Bittigau P, Deller T, et al. (2004) Entorhinal cortex lesion in the mouse induces transsynaptic death of perforant path target neurons. Brain Pathol 14: 249-257.
26. Stoppini L, Buchs PA, Muller D, (1991) A simple method for organotypic cultures of nervous tissue. J Neurosci Methods 37: 173-182.
27. Ramirez JJ, (2001) The role of axonal sprouting in functional reorganization after CNS injury: lessons from the hippocampal formation. Restor Neurol Neurosci 19: 237-262.
28. Brewer GJ, Torricelli JR, Evege EK, Price PJ, (1993) Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 35: 567-576.
29. Del Turco D, Deller T, (2007) Organotypic entorhino-hippocampal slice cultures-a tool to study the molecular and cellular regulation of axonal regeneration and collateral sprouting in vitro. Methods Mol Biol 399: 55-66.
30. Bishay P, Schmidt H, Marian C, Haussler A, Wijnvoord N, et al. (2010) R-flurbiprofen reduces neuropathic pain in rodents by restoring endogenous cannabinoids. PLoS One 5: e10628.
31. Kallendrusch S, Hobusch C, Ehrlich A, Ziebell S, Ueda N, et al. (2012) Site-specific and time-dependent activation of the endocannabinoid system after transection of long-range projections. PLoS One 7: e33537.
32. Signoretti S, Vagnozzi R, Tavazzi B, Lazzarino G, (2010) Biochemical and neurochemical sequelae following mild traumatic brain injury: summary of experimental data and clinical implications. Neurosurg Focus 29: E1.
33. van der Stelt M, Di Marzo V, (2005) Cannabinoid receptors and their role in neuroprotection. Neuromolecular Med 7: 37-50.
34. Milton NG, (2002) Anandamide and noladin ether prevent neurotoxicity of the human amyloid-beta peptide. Neurosci Lett 332: 127-130.
35. Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C, (2002) Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem 80: 448-456.
36. Kristensen BW, Noraberg J, Zimmer J, (2001) Comparison of excitotoxic profiles of ATPA, AMPA, KA and NMDA in organotypic hippocampal slice cultures. Brain Res 917: 21-44.
37. Ludanyi A, Hu SS, Yamazaki M, Tanimura A, Piomelli D, et al. (2011) Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience 174: 50-63.
38. Uchigashima M, Yamazaki M, Yamasaki M, Tanimura A, Sakimura K, et al. (2011) Molecular and morphological configuration for 2-arachidonoylglycerol-mediated retrograde signaling at mossy cell-granule cell synapses in the dentate gyrus. J Neurosci 31: 7700-7714.
39. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, et al. (2006) Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26: 5628-5637.
40. Stella N, Schweitzer P, Piomelli D, (1997) A second endogenous cannabinoid that modulates long-term potentiation. Nature 388: 773-778.
41. Pan B, Wang W, Zhong P, Blankman JL, Cravatt BF, et al. (2011) Alterations of endocannabinoid signaling, synaptic plasticity, learning, and memory in monoacylglycerol lipase knock-out mice. J Neurosci 31: 13420-13430.
42. Straiker A, Wager-Miller J, Hu SS, Blankman JL, Cravatt BF, et al. (2011) COX-2 and fatty acid amide hydrolase can regulate the time course of depolarization-induced suppression of excitation. Br J Pharmacol 164: 1672-1683.
43. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, et al. (2010) Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 30: 2017-2024.
44. Goncalves MB, Suetterlin P, Yip P, Molina-Holgado F, Walker DJ, et al. (2008) A diacylglycerol lipase-CB2 cannabinoid pathway regulates adult subventricular zone neurogenesis in an age-dependent manner. Mol Cell Neurosci 38: 526-536.
45. Garcia-Ovejero D, Arevalo-Martin A, Petrosino S, Docagne F, Hagen C, et al. (2009) The endocannabinoid system is modulated in response to spinal cord injury in rats. Neurobiol Dis 33: 57-71.
46. Yazaki M, Kashiwagi K, Aritake K, Urade Y, Fujimori K, (2012) Rapid degradation of cyclooxygenase-1 and hematopoietic prostaglandin D synthase through ubiquitin-proteasome system in response to intracellular calcium level. Mol Biol Cell 23: 12-21.
47. Yin H, Gui Y, Du G, Frohman MA, Zheng XL, (2010) Dependence of phospholipase D1 multi-monoubiquitination on its enzymatic activity and palmitoylation. J Biol Chem 285: 13580-13588.
48. Clague MJ, Urbe S, (2010) Ubiquitin: same molecule, different degradation pathways. Cell 143: 682-685.
49. Wickliffe K, Williamson A, Jin L, Rape M, (2009) The multiple layers of ubiquitin-dependent cell cycle control. Chem Rev 109: 1537-1548.
50. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, et al. (2006) Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 26: 4740-4751.
51. Uchigashima M, Narushima M, Fukaya M, Katona I, Kano M, et al. (2007) Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-mediated retrograde signaling and its physiological contribution to synaptic modulation in the striatum. J Neurosci 27: 3663-3676.
52. Gomez O, Arevalo-Martin A, Garcia-Ovejero D, Ortega-Gutierrez S, Cisneros JA, et al. (2010) The constitutive production of the endocannabinoid 2-arachidonoylglycerol participates in oligodendrocyte differentiation. Glia 58: 1913-1927.
53. Walter L, Dinh T, Stella N, (2004) ATP induces a rapid and pronounced increase in 2-arachidonoylglycerol production by astrocytes, a response limited by monoacylglycerol lipase. J Neurosci 24: 8068-8074.
54. Walter L, Franklin A, Witting A, Wade C, Xie Y, et al. (2003) Nonpsychotropic cannabinoid receptors regulate microglial cell migration. J Neurosci 23: 1398-1405.
55. Witting A, Chen L, Cudaback E, Straiker A, Walter L, et al. (2006) Experimental autoimmune encephalomyelitis disrupts endocannabinoid-mediated neuroprotection. Proc Natl Acad Sci U S A 103: 6362-6367.
56. Stella N, (2004) Cannabinoid signaling in glial cells. Glia 48: 267-277.
57. Fernandez-Ruiz J, Pazos MR, Garcia-Arencibia M, Sagredo O, Ramos JA, (2008) Role of CB2 receptors in neuroprotective effects of cannabinoids. Mol Cell Endocrinol 286: S91-96.
58. Savinainen JR, Saario SM, Laitinen JT, (2012) The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol (Oxf) 204: 267-276.
59. Fiskerstrand T, H'Mida-Ben Brahim D, Johansson S, M'Zahem A, Haukanes BI, et al. (2010) Mutations in ABHD12 cause the neurodegenerative disease PHARC: An inborn error of endocannabinoid metabolism. Am J Hum Genet 87: 410-417.
60. McPartland JM, Norris RW, Kilpatrick CW, (2007) Coevolution between cannabinoid receptors and endocannabinoid ligands. Gene 397: 126-135.
61. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, et al. (2010) Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13: 1113-1119.
62. Chanda PK, Gao Y, Mark L, Btesh J, Strassle BW, et al. (2010) Monoacylglycerol lipase activity is a critical modulator of the tone and integrity of the endocannabinoid system. Mol Pharmacol 78: 996-1003.
63. Zhao Y, Yuan Z, Liu Y, Xue J, Tian Y, et al. (2010) Activation of cannabinoid CB2 receptor ameliorates atherosclerosis associated with suppression of adhesion molecules. J Cardiovasc Pharmacol 55: 292-298.
64. Degn M, Lambertsen KL, Petersen G, Meldgaard M, Artmann A, et al. (2007) Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. J Neurochem 103: 1907-1916.
65. Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, et al. (2006) The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 22: 257-264.